Comparing two types of peanut oral immunotherapy for peanut allergy
Part of Immune system & allergy clinical trials.
This study compares two types of peanut oral immunotherapy (gradually eating small amounts of peanut to build tolerance) — one using standard peanut flour and one using a special autoclaved (heat-treated) version that may cause fewer reactions. The goal is to see if the autoclaved form is safer and just as effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 4 and 30 years old.
- You need a doctor-confirmed peanut allergy (from a skin prick test, blood test, or a past reaction).
- Your asthma or any other lung condition must be well controlled.
- You cannot be taking immunosuppressant drugs or beta-blockers (including eye drops).
- You cannot have certain heart conditions, uncontrolled high blood pressure, or an active infection or inflammation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new approach to oral immunotherapy for food allergies, aiming to make it safer and more effective. It's for people who have had a clear allergic reaction to a food and have a positive allergy test.
This trial tests an oral (by mouth) immune treatment for people with confirmed peanut allergy. It aims to see whether your immune system can become less reactive to peanuts over time, while keeping you safe during testing with careful emergency planning.
This Phase 2 study tests whether taking capsules made from donor gut microbes is safe and can reduce allergic reactions to peanuts. It involves peanut allergy testing and close follow-up with stool samples and check-ins.
This trial tests whether adding tezepelumab (a biologic drug) to peanut oral immunotherapy can help people with peanut allergy better tolerate small amounts of peanut protein without having an allergic reaction.
This trial tests a new peanut allergy treatment called ENP-501. It aims to see if the medicine can safely help people with peanut allergy become less sensitive to peanuts.
This trial studies whether an immune-supportive diet can improve gut health (gut permeability) in children with confirmed peanut or tree-nut allergy. If you join, the researchers will use allergy testing and gut-related diet approaches to see whether symptoms and gut measures change.
Hear when a new Peanut Allergy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.